CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleRevenue is $772.45M, above the global median of $548.88M
- FinancialsAltman Z-Score 2.57: grey zone
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.95%Above 5Y avg (1.09%)
Annual Rate
KRW 160.00Paid annual
Payout Ratio
11.1%Sustainable
Payback Period
52.6 yr
Last Ex-Dividend
Dec 29, 2025
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
691.52BKRW503.77M · vs all stocks (USD)
Trailing P/E
10.73xRevenue (TTM)
1.06TKRW772.45M · vs all stocks (USD)
Profit Margin
11.37%Beta
0.3290xvs all stocks
52-Week Change
-6.91%vs all stocks
Market Capitalization
691.52BKRW503.77M · vs all stocks (USD)
Enterprise Value
947.87BKRW690.53M · vs all stocks (USD)
Trailing P/E
10.73xForward P/E
10.34xPEG Ratio
0.0628xPrice to Sales (TTM)
0.6545xPrice to Book (MRQ)
0.7700xEnterprise to Revenue
0.8940xEnterprise to EBITDA
7.89xGross Margin
37.42%Profit Margin
11.37%Operating Margin
8.51%Return on Assets (TTM)
3.19%Return on Equity (TTM)
14.38%Revenue (TTM)
1.06TKRW772.45M · vs all stocks (USD)
Revenue per Share (TTM)
12.63KKRWUpdated Sep 21, 2026Quarterly Revenue Growth
11.20%Gross Profit (TTM)
387.40BKRW282.22M · vs all stocks (USD)
EBITDA (TTM)
181.57BKRW132.27M · vs all stocks (USD)
Net Income (TTM)
120.58BKRW87.84M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
171.40%Operating Cash Flow (TTM)
150.19BKRW109.41M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-218.14BKRW-158.91M · vs all stocks (USD)
Trailing Annual Dividend Rate
160.00KRWUpdated Sep 21, 2026Trailing Annual Dividend Yield
1.95%vs all stocks
5-Year Average Dividend Yield
1.09%vs all stocks
Payout Ratio
11.14%Revenue
1.02TKRWFY2025 · Dec 31, 2025Cost of Goods Sold
645.14BKRWFY2025 · Dec 31, 2025Gross Profit
372.28BKRWFY2025 · Dec 31, 2025Operating Income
65.07BKRW47.40M · vs all stocks (USD)
Pre-tax Income
69.85BKRWFY2025 · Dec 31, 2025Income Tax Expense
5.55BKRWFY2025 · Dec 31, 2025Net Income
64.30BKRWFY2025 · Dec 31, 2025EBIT
81.42BKRWFY2025 · Dec 31, 2025EBITDA (Income Statement)
113.38BKRWFY2025 · Dec 31, 2025Research & Development
65.09BKRWFY2025 · Dec 31, 2025Selling, General & Administrative
99.58BKRWFY2025 · Dec 31, 2025Other Operating Expenses
5.98BKRWFY2025 · Dec 31, 2025Non-operating Interest Income
8.56BKRWFY2025 · Dec 31, 2025Non-operating Interest Expense
11.58BKRWFY2025 · Dec 31, 2025EPS (Basic)
766.00KRWFY2025 · Dec 31, 2025EPS (Diluted)
766.00KRWFY2025 · Dec 31, 2025Basic Shares Outstanding
83.95MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
83.95MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
64.30BKRWFY2025 · Dec 31, 2025Operating Cash Flow
93.61BKRWFY2025 · Dec 31, 2025Free Cash Flow
71.39BKRWFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
227.61BKRWFY2025 · Dec 31, 2025Starting Profit (CF Statement)
64.30BKRWFY2025 · Dec 31, 2025Stock-based Compensation
-75.80MKRWFY2025 · Dec 31, 2025Other Non-cash Items
3.25BKRWFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
17.21BKRWFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
8.92BKRWFY2025 · Dec 31, 2025Capital Expenditures
-22.22BKRWFY2025 · Dec 31, 2025Net Intangibles (CF)
-7.65BKRWFY2025 · Dec 31, 2025Purchase of Investments
-25.15BKRWFY2025 · Dec 31, 2025Sale of Investments
4.67BKRWFY2025 · Dec 31, 2025Other Investing Activity
-176.35BKRWFY2025 · Dec 31, 2025Net Investing Cash Flow
-219.04BKRWFY2025 · Dec 31, 2025Long-term Debt Issuance
199.37BKRWFY2025 · Dec 31, 2025Long-term Debt Payments
-78.08BKRWFY2025 · Dec 31, 2025Net Short-term Debt Issuance
-3.33BKRWFY2025 · Dec 31, 2025Common Dividends Paid
-8.40BKRWFY2025 · Dec 31, 2025Other Financing Charges
-13.43MKRWFY2025 · Dec 31, 2025Net Financing Cash Flow
109.55BKRWFY2025 · Dec 31, 2025Shares Outstanding
84.48MSharesUpdated Sep 21, 2026Float Shares
28.14MSharesUpdated Sep 21, 2026% Held by Insiders
65.77%vs all stocks
% Held by Institutions
6.42%vs all stocks
Total Cash (MRQ)
135.03BKRW98.37M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.61KKRWUpdated Sep 21, 2026Total Debt (MRQ)
388.86BKRW283.29M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.4346xCurrent Ratio (MRQ)
1.71xBook Value per Share (MRQ)
10.68KKRWUpdated Sep 21, 2026Total Assets
1.39TKRW1.01B · vs all stocks (USD)
Total Current Assets
662.94BKRWFY2025 · Dec 31, 2025Total Liabilities
542.38BKRWFY2025 · Dec 31, 2025Total Non-current Assets
724.94BKRWFY2025 · Dec 31, 2025Total Non-current Liabilities
287.41BKRWFY2025 · Dec 31, 2025Total Current Liabilities
254.97BKRWFY2025 · Dec 31, 2025Cash Equivalents
227.61BKRWFY2025 · Dec 31, 2025Cash & Cash Equivalents
227.61BKRWFY2025 · Dec 31, 2025Other Short-term Investments
27.07BKRWFY2025 · Dec 31, 2025Accounts Receivable
168.44BKRWFY2025 · Dec 31, 2025Inventory
219.44BKRWFY2025 · Dec 31, 2025Accounts Payable
98.52BKRWFY2025 · Dec 31, 2025Short-term Debt
70.92BKRWFY2025 · Dec 31, 2025Other Current Liabilities
25.32BKRWFY2025 · Dec 31, 2025Long-term Debt
259.10BKRWFY2025 · Dec 31, 2025Other Non-current Liabilities
4.54BKRWFY2025 · Dec 31, 2025Common Stock (Book)
43.39BKRWFY2025 · Dec 31, 2025Retained Earnings
518.81BKRWFY2025 · Dec 31, 2025Total Shareholders' Equity
845.50BKRW615.95M · vs all stocks (USD)
Treasury Stock
16.80BKRWFY2025 · Dec 31, 202552-Week Low
7.41KKRWUpdated Sep 21, 202652-Week High
10.80KKRWUpdated Sep 21, 202652-Week Change
-6.91%vs all stocks
Beta
0.3290xvs all stocks
50-Day MA
8.65KKRWUpdated Sep 21, 2026200-Day MA
9.11KKRWUpdated Sep 21, 2026Avg 10-Day Volume
154.16KSharesUpdated Sep 21, 2026Avg 30-Day Volume
115.51KSharesUpdated Sep 21, 2026Diluted EPS (TTM)
766.00KRWUpdated Sep 21, 20262 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
How is this stock valued?
Close Below 40W SMA With Profitability
The price sits below its 40-week average, on three profitable years and cash above profit.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 2.57: grey zoneSignificant
Altman Z-Score: 2.57
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Revenue is $772.45M, above the global median of $548.88MNotable
Revenue (USD): 772,454,424.642Global Median: 548,883,780.48
Companies that share the same coordination system — how they create, deliver, or capture value.
Pacific Biosciences of California, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Puma Biotechnology Inc.
Tier 1ProductionApproval-Gated PipelineRule
Jiangsu Bioperfectus Technologies Co., Ltd.
Tier 1ProductionApproval-Gated PipelineFlowRule
Ever Supreme Bio Technology Co., Ltd
Tier 1ProductionApproval-Gated PipelineRuleFlow
Bright Minds Biosciences Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Ningbo David Medical Device Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Beijing Succeeder Technology Inc.
Tier 1ProductionApproval-Gated PipelineRule
Jiangsu Hanbon Science & Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Hinova Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Oculis Holding AG
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Eis Eczacıbaşı İlaç ve Sanayi A.Ş.
2 interpretationsMulti-Year Revenue, Profit, And Income GrowthClose Below 40W SMA With Profitability
Easy Holdings Co., Ltd.
2 interpretationsMulti-Year Revenue, Profit, And Income GrowthClose Below 40W SMA With Profitability
India Glycols Ltd.
2 interpretationsMulti-Year Revenue, Profit, And Income GrowthClose Below 40W SMA With Profitability